Advertisement
Australia markets closed
  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     
  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     
  • AUD/USD

    0.6425
    -0.0001 (-0.01%)
     
  • OIL

    83.18
    +0.45 (+0.54%)
     
  • GOLD

    2,398.40
    +0.40 (+0.02%)
     
  • Bitcoin AUD

    101,017.90
    +5,112.15 (+5.33%)
     
  • CMC Crypto 200

    1,332.62
    +20.00 (+1.55%)
     
  • AUD/EUR

    0.6023
    -0.0008 (-0.13%)
     
  • AUD/NZD

    1.0894
    +0.0019 (+0.17%)
     
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NASDAQ

    17,394.31
    -99.31 (-0.57%)
     
  • FTSE

    7,834.59
    -42.46 (-0.54%)
     
  • Dow Jones

    37,775.38
    +22.07 (+0.06%)
     
  • DAX

    17,718.81
    -118.59 (-0.66%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

Pandemic-driven cleaning routines boost P&G sales forecast again

FILE PHOTO: Procter & Gamble's Oral-B toothbrush heads are seen in a store in Manhattan, New York, U.S.

By Siddharth Cavale and Uday Sampath Kumar

(Reuters) - Procter & Gamble Co raised its full-year sales forecast for a second time on Wednesday as it benefited from sustained coronavirus-driven demand for cleaning products, while also warning that the pace of sales might slow as vaccines roll out.

The Cincinnati-based conglomerate reported an 8% rise in net sales for its second quarter, slower than 9% growth in the first quarter but showing the boom in household cleaning purchases was continuing.

P&G said Americans were cleaning and sanitizing 30% more than before the pandemic. Dishwasher cycles were run 15% more and air fresheners sprayed 20% more often while in-home paper towel usage was up 15%.

ADVERTISEMENT

The company saw a 30% rise in organic sales of its home care products in the second quarter, while consumer willingness to pay for more premium brands over store-branded goods helped sales of items like Downy laundry beads and Tide pods.

P&G's shares, which rose as much as 2.5% initially, lost all those gains after executives warned that the rollout of vaccines was liable to cool those trends.

"Could there be some reduction in top line growth rates if, God-willing, the situation gets better, and therefore, I need less in my pantry as protection? Yes, that could occur," finance and operating chief Jon Moeller said.

Still, P&G raised its fiscal 2021 sales growth forecast to a range of 5% to 6%, from 3% to 4%, mainly on the back of a strong first half.

It also lifted its core earnings per share growth forecast to 8% to 10%, from 5% to 8%, and said organic sales are now expected to grow 5% to 6%, compared with 4% to 5% it anticipated earlier.

The company will also buy back up to $10 billion worth of shares in fiscal 2021, up from the $7 billion to $9 billion target it set earlier, and Moeller pointed to the likelihood of a boost from new fiscal stimulus under Joe Biden's presidency.

"It's a rather uncertain environment, but where stimulus has existed it has helped and more of it will help more," he said.

(Reporting by Siddharth Cavale and Uday Sampath in Bengaluru; Editing by Maju Samuel and Patrick Graham)